JP2024536609A5 - - Google Patents
Info
- Publication number
- JP2024536609A5 JP2024536609A5 JP2024524678A JP2024524678A JP2024536609A5 JP 2024536609 A5 JP2024536609 A5 JP 2024536609A5 JP 2024524678 A JP2024524678 A JP 2024524678A JP 2024524678 A JP2024524678 A JP 2024524678A JP 2024536609 A5 JP2024536609 A5 JP 2024536609A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- oral formulation
- coated
- hpmcas
- formulation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2021/079584 WO2023072368A1 (en) | 2021-10-25 | 2021-10-25 | Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of intestinal fibrosis |
| EPPCT/EP2021/079584 | 2021-10-25 | ||
| PCT/EP2022/079666 WO2023072878A1 (en) | 2021-10-25 | 2022-10-24 | Oral formulation of a pyridinone derivate and use thereof in prophylaxis and/or treatment of intestinal fibrosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024536609A JP2024536609A (ja) | 2024-10-04 |
| JP2024536609A5 true JP2024536609A5 (cg-RX-API-DMAC7.html) | 2025-11-05 |
Family
ID=78536154
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024524678A Pending JP2024536609A (ja) | 2021-10-25 | 2022-10-24 | ピリジノン誘導体の経口製剤および腸線維症の予防および/または治療におけるその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250041228A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4312994A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024536609A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240093898A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118234489A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022374695A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3230682A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312176A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005076A (cg-RX-API-DMAC7.html) |
| WO (2) | WO2023072368A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA202402786B (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL297020A (en) | 2020-04-24 | 2022-12-01 | Dr Falk Pharma Gmbh | A systemic preparation of a pyridonone derivative related to tg2 |
| HRP20231072T1 (hr) | 2020-04-24 | 2023-12-22 | Dr. Falk Pharma Gmbh | Sustavna formulacija derivata piridinona za celijakiju |
| WO2025153465A1 (en) * | 2024-01-15 | 2025-07-24 | UCB Biopharma SRL | Method for the treatment of fibrotic-related disorder associated to ibd |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102006052755A1 (de) * | 2006-11-08 | 2008-05-15 | N-Zyme Biotec Gmbh | Michaelsysteme als Transglutaminaseinhibitoren |
| EP2687511A1 (de) * | 2012-07-17 | 2014-01-22 | Zedira GmbH | Pyridinonderivate als Gewebetransglutaminaseinhibitoren |
-
2021
- 2021-10-25 WO PCT/EP2021/079584 patent/WO2023072368A1/en not_active Ceased
-
2022
- 2022-10-24 CN CN202280071095.9A patent/CN118234489A/zh active Pending
- 2022-10-24 JP JP2024524678A patent/JP2024536609A/ja active Pending
- 2022-10-24 US US18/704,228 patent/US20250041228A1/en active Pending
- 2022-10-24 CA CA3230682A patent/CA3230682A1/en active Pending
- 2022-10-24 EP EP22809386.0A patent/EP4312994A1/en active Pending
- 2022-10-24 MX MX2024005076A patent/MX2024005076A/es unknown
- 2022-10-24 KR KR1020247017206A patent/KR20240093898A/ko active Pending
- 2022-10-24 AU AU2022374695A patent/AU2022374695A1/en active Pending
- 2022-10-24 IL IL312176A patent/IL312176A/en unknown
- 2022-10-24 WO PCT/EP2022/079666 patent/WO2023072878A1/en not_active Ceased
-
2024
- 2024-04-10 ZA ZA2024/02786A patent/ZA202402786B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5705319B2 (ja) | 1種以上のアルギン酸の塩を含む胃液抵抗性の医薬又は栄養補助製剤 | |
| JP2011513204A5 (cg-RX-API-DMAC7.html) | ||
| JP2002527468A (ja) | 脈動用量薬剤経口送達システム | |
| KR102381586B1 (ko) | 메살라진의 경구용 약제학적 조성물 | |
| AU3492201A (en) | Timed pulsatile drug delivery systems | |
| JP2009538315A (ja) | 塩酸デュロキセチン遅延放出型製剤 | |
| NZ547284A (en) | Pharmaceutical agent-containing formulation comprising a coating of a film forming polymer | |
| US20100247645A1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
| CN101010070A (zh) | 药物组合物 | |
| JP2024506595A5 (cg-RX-API-DMAC7.html) | ||
| CN101861138A (zh) | 控释的阿奇霉素固体剂型 | |
| JPH0826977A (ja) | 溶出制御型経口製剤 | |
| JP2024536609A (ja) | ピリジノン誘導体の経口製剤および腸線維症の予防および/または治療におけるその使用 | |
| AU2018286535B2 (en) | Delayed sustained release pharmaceutical compositions | |
| JP7021108B2 (ja) | ニコチンアミドの経口薬学的組成物 | |
| JP2007530492A5 (cg-RX-API-DMAC7.html) | ||
| CN100361660C (zh) | 左氧氟沙星缓释微丸、其制备方法及其制药用途 | |
| JP7423629B2 (ja) | 結腸ドラッグデリバリー製剤 | |
| WO2005051362A2 (en) | Oral benzimidazole compositions comprising an active core, an optional separating layer and an enteric coating | |
| US10946002B2 (en) | Pharmaceutical suspension dosage form of benzimidazole compounds and process of preparation thereof | |
| TW201813643A (zh) | 杜洛希酊腸衣包覆醫藥組成物及其製造方法 | |
| TWI408130B (zh) | 度若西汀腸衣組合物 | |
| KR20070042073A (ko) | 새로운 서방성 다중 유닛 제형 | |
| HK40005191B (en) | Oral pharmaceutical compositions of nicotinamide | |
| HK40005191A (en) | Oral pharmaceutical compositions of nicotinamide |